Delivery Order SPE2DB20D3111-SPE2DB25FA6ZJ
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of the pharmaceutical product "XULANE 150-35 MCG/DAY PATCH 3S," with a ceiling value of $2,794.00 and a period of performance through March 7, 2025. The contract is a firm fixed-price delivery order, which is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product, with a ceiling value of $2,414.59 and a period of performance through November 10, 2022. The contract is a firm fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a prescription medication, with a ceiling value of $1,921.42 and a performance period ending on June 18, 2025. The contract is a Firm Fixed Price type and is not set aside for any specific business category. AmerisourceBergen Drug Corp is the prime...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract, with a ceiling value of $4,516.48, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S medical products. The contract has an ultimate completion date of March 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,242.91, is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product. The contract has an ultimate completion date of February 25, 2025 and is a Firm Fixed Price contract. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a ceiling value of $2,840.60 and a completion date of June 17, 2025. The contract is a firm fixed-price, non-set-aside arrangement. AmerisourceBergen Drug Corp is the prime contractor, and there is no information provided about any subcontractors....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $1,624.20. The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of June 21, 2024 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a ceiling value of $6,417.56 and a period of performance through June 16, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a medical supply item, with a ceiling value of $3,109.62. The contract has an ultimate completion date of June 27, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has a firm fixed price of $1,952.24 and an ultimate completion date of August 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows the DLA Troop Support Medical to procure a comprehensive range of medical...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA6ZJDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a ceiling value of $4,213.85 and a period of performance through March 11, 2025. The contract is a firm fixed price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 3/10/25 |